MDxHealth is trading at $0.67, down 5.09%, on September 15, 2026, amid broad risk-off pressure as major U.S. indexes decline and Treasury yields reach a 19-year high.
- No new company-specific announcement or analyst action dated September 15 was identified.
- Latest notable developments were earlier 2026 results, financing, and reimbursement-related news.
- Healthcare is outperforming, so sector weakness does not explain the decline.